Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Zoetis to Participate in the Stifel 2024 Jaws and Paws Conference By: Zoetis Inc. via Business Wire May 16, 2024 at 08:30 AM EDT Zoetis Inc. (NYSE:ZTS) will participate in the Stifel 2024 Jaws and Paws Conference on Wednesday, May 29, 2024. Kristin Peck, Chief Executive Officer, will represent the company and respond to questions from analysts. She is scheduled to present at 12:05 p.m. ET. Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting http://investor.zoetis.com/events-presentations. A replay of the presentation will also be available on the Zoetis website at the conclusion of the event. About Zoetis As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers and ranchers. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $8.5 billion in 2023 with approximately 14,100 employees. For more information, visit www.zoetis.com. ZTS-COR ZTS-IR View source version on businesswire.com: https://www.businesswire.com/news/home/20240516542873/en/Contacts Media Contacts: Jenielle Alonso 1-973-945-4333 (o) jenielle.alonso@zoetis.com Laura Panza 1-973-975-5176 (o) laura.panza@zoetis.com Investor Contacts: Steve Frank 1-973-822-7141 (o) steve.frank@zoetis.com Nick Soonthornchai 1-973-443-2792 (o) nick.soonthornchai@zoetis.com Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Zoetis to Participate in the Stifel 2024 Jaws and Paws Conference By: Zoetis Inc. via Business Wire May 16, 2024 at 08:30 AM EDT Zoetis Inc. (NYSE:ZTS) will participate in the Stifel 2024 Jaws and Paws Conference on Wednesday, May 29, 2024. Kristin Peck, Chief Executive Officer, will represent the company and respond to questions from analysts. She is scheduled to present at 12:05 p.m. ET. Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting http://investor.zoetis.com/events-presentations. A replay of the presentation will also be available on the Zoetis website at the conclusion of the event. About Zoetis As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers and ranchers. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $8.5 billion in 2023 with approximately 14,100 employees. For more information, visit www.zoetis.com. ZTS-COR ZTS-IR View source version on businesswire.com: https://www.businesswire.com/news/home/20240516542873/en/Contacts Media Contacts: Jenielle Alonso 1-973-945-4333 (o) jenielle.alonso@zoetis.com Laura Panza 1-973-975-5176 (o) laura.panza@zoetis.com Investor Contacts: Steve Frank 1-973-822-7141 (o) steve.frank@zoetis.com Nick Soonthornchai 1-973-443-2792 (o) nick.soonthornchai@zoetis.com
Zoetis Inc. (NYSE:ZTS) will participate in the Stifel 2024 Jaws and Paws Conference on Wednesday, May 29, 2024. Kristin Peck, Chief Executive Officer, will represent the company and respond to questions from analysts. She is scheduled to present at 12:05 p.m. ET. Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting http://investor.zoetis.com/events-presentations. A replay of the presentation will also be available on the Zoetis website at the conclusion of the event. About Zoetis As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers and ranchers. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $8.5 billion in 2023 with approximately 14,100 employees. For more information, visit www.zoetis.com. ZTS-COR ZTS-IR View source version on businesswire.com: https://www.businesswire.com/news/home/20240516542873/en/
Media Contacts: Jenielle Alonso 1-973-945-4333 (o) jenielle.alonso@zoetis.com Laura Panza 1-973-975-5176 (o) laura.panza@zoetis.com Investor Contacts: Steve Frank 1-973-822-7141 (o) steve.frank@zoetis.com Nick Soonthornchai 1-973-443-2792 (o) nick.soonthornchai@zoetis.com